Clinical Trials Browser

Phase 2 × Sarcoma × RG-1507 monoclonal antibody × Clear all

NCT00642941 2021-02-03

A Study of R1507 in Participants With Recurrent or Refractory Sarcoma

Phase 2 Terminated

317 enrolled 27 charts

Sarcoma